

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 5.91012240 |
| 2 | locomotory exploration behavior (GO:0035641) | 5.79214851 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.30880494 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.19224178 |
| 5 | regulation of synapse structural plasticity (GO:0051823) | 4.81442298 |
| 6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.72472392 |
| 7 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.53441141 |
| 8 | vocalization behavior (GO:0071625) | 4.48464902 |
| 9 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.27720332 |
| 10 | sodium ion export (GO:0071436) | 4.20773411 |
| 11 | glutamate secretion (GO:0014047) | 4.20431969 |
| 12 | synaptic vesicle exocytosis (GO:0016079) | 4.18141450 |
| 13 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.17542500 |
| 14 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.01786133 |
| 15 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.98552520 |
| 16 | * regulation of glutamate receptor signaling pathway (GO:1900449) | 3.92004834 |
| 17 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.86238043 |
| 18 | exploration behavior (GO:0035640) | 3.85590590 |
| 19 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.84810519 |
| 20 | neurotransmitter secretion (GO:0007269) | 3.83724748 |
| 21 | neuromuscular process controlling balance (GO:0050885) | 3.82681761 |
| 22 | layer formation in cerebral cortex (GO:0021819) | 3.82235151 |
| 23 | * regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.81129879 |
| 24 | cellular potassium ion homeostasis (GO:0030007) | 3.78674221 |
| 25 | prepulse inhibition (GO:0060134) | 3.76643341 |
| 26 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.73155342 |
| 27 | activation of protein kinase A activity (GO:0034199) | 3.69893369 |
| 28 | dendritic spine morphogenesis (GO:0060997) | 3.67774298 |
| 29 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.63978551 |
| 30 | regulation of ARF protein signal transduction (GO:0032012) | 3.62210198 |
| 31 | regulation of synaptic vesicle transport (GO:1902803) | 3.58342461 |
| 32 | protein localization to endosome (GO:0036010) | 3.54233970 |
| 33 | neuronal action potential propagation (GO:0019227) | 3.50788866 |
| 34 | gamma-aminobutyric acid transport (GO:0015812) | 3.49588919 |
| 35 | mannose metabolic process (GO:0006013) | 3.47388390 |
| 36 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.47238209 |
| 37 | long-term memory (GO:0007616) | 3.46091473 |
| 38 | glycine transport (GO:0015816) | 3.39973667 |
| 39 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.39326666 |
| 40 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.35631304 |
| 41 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.34549256 |
| 42 | protein localization to synapse (GO:0035418) | 3.32714226 |
| 43 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.32425353 |
| 44 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.30451039 |
| 45 | proline transport (GO:0015824) | 3.29166972 |
| 46 | desmosome organization (GO:0002934) | 3.29106272 |
| 47 | positive regulation of membrane potential (GO:0045838) | 3.27925114 |
| 48 | auditory behavior (GO:0031223) | 3.27638626 |
| 49 | synaptic transmission, glutamatergic (GO:0035249) | 3.26565579 |
| 50 | regulation of synaptic plasticity (GO:0048167) | 3.25451905 |
| 51 | adenosine receptor signaling pathway (GO:0001973) | 3.19888290 |
| 52 | hemidesmosome assembly (GO:0031581) | 3.15227903 |
| 53 | cell communication by electrical coupling (GO:0010644) | 3.11040365 |
| 54 | regulation of early endosome to late endosome transport (GO:2000641) | 3.09092855 |
| 55 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.04456230 |
| 56 | neuron-neuron synaptic transmission (GO:0007270) | 3.04424355 |
| 57 | cell-substrate junction assembly (GO:0007044) | 3.04421058 |
| 58 | regulation of postsynaptic membrane potential (GO:0060078) | 3.03467398 |
| 59 | neuronal ion channel clustering (GO:0045161) | 3.02612704 |
| 60 | neuromuscular process controlling posture (GO:0050884) | 3.02206803 |
| 61 | potassium ion import (GO:0010107) | 3.02119179 |
| 62 | response to auditory stimulus (GO:0010996) | 3.01908570 |
| 63 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.01873407 |
| 64 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.99855764 |
| 65 | adherens junction assembly (GO:0034333) | 2.99676655 |
| 66 | glutamate receptor signaling pathway (GO:0007215) | 2.98579587 |
| 67 | L-amino acid import (GO:0043092) | 2.98454538 |
| 68 | focal adhesion assembly (GO:0048041) | 2.92064738 |
| 69 | cell-substrate adherens junction assembly (GO:0007045) | 2.92064738 |
| 70 | regulation of ARF GTPase activity (GO:0032312) | 2.91023230 |
| 71 | neurotransmitter transport (GO:0006836) | 2.89664609 |
| 72 | cellular sodium ion homeostasis (GO:0006883) | 2.89384478 |
| 73 | response to laminar fluid shear stress (GO:0034616) | 2.89107090 |
| 74 | activation of Rac GTPase activity (GO:0032863) | 2.87589090 |
| 75 | positive regulation of neurotransmitter transport (GO:0051590) | 2.86899178 |
| 76 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.85882524 |
| 77 | regulation of neurotransmitter levels (GO:0001505) | 2.85485723 |
| 78 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.83643362 |
| 79 | vesicle transport along microtubule (GO:0047496) | 2.83351067 |
| 80 | regulation of Rap GTPase activity (GO:0032317) | 2.81833961 |
| 81 | dopamine receptor signaling pathway (GO:0007212) | 2.81323224 |
| 82 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.80958306 |
| 83 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.80602877 |
| 84 | regulation of extracellular matrix disassembly (GO:0010715) | 2.79395899 |
| 85 | semaphorin-plexin signaling pathway (GO:0071526) | 2.79000505 |
| 86 | regulation of female receptivity (GO:0045924) | 2.78456813 |
| 87 | membrane depolarization during action potential (GO:0086010) | 2.76682365 |
| 88 | positive regulation of synapse maturation (GO:0090129) | 2.76524219 |
| 89 | positive regulation of Rap GTPase activity (GO:0032854) | 2.75935714 |
| 90 | long-term synaptic potentiation (GO:0060291) | 2.75807761 |
| 91 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.74876360 |
| 92 | transmission of nerve impulse (GO:0019226) | 2.74853110 |
| 93 | neuromuscular process (GO:0050905) | 2.74852230 |
| 94 | signal complex assembly (GO:0007172) | 2.74599753 |
| 95 | dendritic spine organization (GO:0097061) | 2.74380880 |
| 96 | regulation of dendritic spine development (GO:0060998) | 2.73501002 |
| 97 | positive regulation of receptor recycling (GO:0001921) | 2.71508847 |
| 98 | cell communication involved in cardiac conduction (GO:0086065) | 2.71023472 |
| 99 | barbed-end actin filament capping (GO:0051016) | 2.70937160 |
| 100 | striatum development (GO:0021756) | 2.70735652 |
| 101 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.70244453 |
| 102 | synaptic vesicle endocytosis (GO:0048488) | 2.69411605 |
| 103 | stress fiber assembly (GO:0043149) | 2.68632344 |
| 104 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.68594276 |
| 105 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.67768949 |
| 106 | regulation of cholesterol homeostasis (GO:2000188) | 2.67761908 |
| 107 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.67031426 |
| 108 | establishment of nucleus localization (GO:0040023) | 2.66533752 |
| 109 | membrane depolarization (GO:0051899) | 2.65576112 |
| 110 | mating behavior (GO:0007617) | 2.64564008 |
| 111 | cAMP biosynthetic process (GO:0006171) | 2.63606732 |
| 112 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.63522319 |
| 113 | amino acid import (GO:0043090) | 2.62625784 |
| 114 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.62445422 |
| 115 | nerve growth factor signaling pathway (GO:0038180) | 2.61576779 |
| 116 | membrane hyperpolarization (GO:0060081) | 2.60776500 |
| 117 | regulation of neurotransmitter secretion (GO:0046928) | 2.59219711 |
| 118 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.59124335 |
| 119 | cell-cell junction maintenance (GO:0045217) | 2.59006500 |
| 120 | alanine transport (GO:0032328) | 2.58363442 |
| 121 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.57921103 |
| 122 | positive regulation of synaptic transmission (GO:0050806) | 2.57529643 |
| 123 | visual learning (GO:0008542) | 2.57434887 |
| 124 | chemosensory behavior (GO:0007635) | 2.56791337 |
| 125 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.56101966 |
| 126 | cerebellar granule cell differentiation (GO:0021707) | 2.55688834 |
| 127 | response to muramyl dipeptide (GO:0032495) | 2.53909600 |
| 128 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.47411982 |
| 129 | negative regulation of cell killing (GO:0031342) | 2.46579216 |
| 130 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.46579216 |
| 131 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.44172467 |
| 132 | COPI coating of Golgi vesicle (GO:0048205) | 2.43943697 |
| 133 | Golgi transport vesicle coating (GO:0048200) | 2.43943697 |
| 134 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.43318710 |
| 135 | cortical actin cytoskeleton organization (GO:0030866) | 2.39508280 |
| 136 | surfactant homeostasis (GO:0043129) | 2.39179361 |
| 137 | positive regulation of protein dephosphorylation (GO:0035307) | 2.38262292 |
| 138 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.37840839 |
| 139 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.37081518 |
| 140 | embryonic process involved in female pregnancy (GO:0060136) | 2.36518712 |
| 141 | activation of JUN kinase activity (GO:0007257) | 2.34581614 |
| 142 | detection of bacterium (GO:0016045) | 2.33503327 |
| 143 | regulation of water loss via skin (GO:0033561) | 2.30603620 |
| 144 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.29093661 |
| 145 | positive regulation of extracellular matrix organization (GO:1903055) | 2.28858235 |
| 146 | detection of other organism (GO:0098543) | 2.28531883 |
| 147 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.28422977 |
| 148 | protein targeting to plasma membrane (GO:0072661) | 2.28139145 |
| 149 | regulation of extracellular matrix organization (GO:1903053) | 2.26775349 |
| 150 | negative regulation of myotube differentiation (GO:0010832) | 2.25409395 |
| 151 | activation of MAPKKK activity (GO:0000185) | 2.24636092 |
| 152 | cell volume homeostasis (GO:0006884) | 2.23322943 |
| 153 | regulation of leukocyte degranulation (GO:0043300) | 2.22358576 |
| 154 | modulation by symbiont of host cellular process (GO:0044068) | 2.21705473 |
| 155 | apoptotic process involved in morphogenesis (GO:0060561) | 2.21584901 |
| 156 | endothelial cell chemotaxis (GO:0035767) | 2.20921594 |
| 157 | myelin maintenance (GO:0043217) | 2.17064611 |
| 158 | protein retention in ER lumen (GO:0006621) | 2.16013632 |
| 159 | skin morphogenesis (GO:0043589) | 2.15242137 |
| 160 | negative regulation of fatty acid transport (GO:2000192) | 2.13499551 |
| 161 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.11491980 |
| 162 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.10974843 |
| 163 | cortical cytoskeleton organization (GO:0030865) | 2.10540130 |
| 164 | positive thymic T cell selection (GO:0045059) | 2.09881664 |
| 165 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.09854960 |
| 166 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.09854960 |
| 167 | modulation by symbiont of host immune response (GO:0052553) | 2.09854960 |
| 168 | positive regulation by symbiont of host defense response (GO:0052509) | 2.09854960 |
| 169 | modulation by symbiont of host defense response (GO:0052031) | 2.09854960 |
| 170 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.09854960 |
| 171 | regulation of lipid kinase activity (GO:0043550) | 2.09692397 |
| 172 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.09083300 |
| 173 | establishment of skin barrier (GO:0061436) | 2.08712784 |
| 174 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.08666603 |
| 175 | pinocytosis (GO:0006907) | 2.08600237 |
| 176 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.07840002 |
| 177 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.07801038 |
| 178 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.07649228 |
| 179 | hypotonic response (GO:0006971) | 2.07630284 |
| 180 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.07466528 |
| 181 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.07430460 |
| 182 | epithelial cell-cell adhesion (GO:0090136) | 2.06196771 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.05887928 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.65128215 |
| 3 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.07762859 |
| 4 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.83938552 |
| 5 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.73127569 |
| 6 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.66237072 |
| 7 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.46519830 |
| 8 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.40130516 |
| 9 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.33848521 |
| 10 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.32147977 |
| 11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.24650510 |
| 12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.24650510 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.20746711 |
| 14 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.18792127 |
| 15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.18300585 |
| 16 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.12977451 |
| 17 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.09645242 |
| 18 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.05717712 |
| 19 | MYC_22102868_ChIP-Seq_BL_Human | 2.05712871 |
| 20 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.04993267 |
| 21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.04792316 |
| 22 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.94795728 |
| 23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.92065555 |
| 24 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.90641968 |
| 25 | KDM2B_26808549_Chip-Seq_K562_Human | 1.90337055 |
| 26 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.86014521 |
| 27 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.85224642 |
| 28 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.82402367 |
| 29 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.80656226 |
| 30 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.76595100 |
| 31 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.76086244 |
| 32 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.75536141 |
| 33 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.74909169 |
| 34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.72804300 |
| 35 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.65103450 |
| 36 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.64070549 |
| 37 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.58175755 |
| 38 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.56838709 |
| 39 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.56622107 |
| 40 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.56020478 |
| 41 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.52603119 |
| 42 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.51297816 |
| 43 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.51156826 |
| 44 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.50693850 |
| 45 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.50242701 |
| 46 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.46307803 |
| 47 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.46193138 |
| 48 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.45360652 |
| 49 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.45045165 |
| 50 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.42989440 |
| 51 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.42818517 |
| 52 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.42460744 |
| 53 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.41560987 |
| 54 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.40774674 |
| 55 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.39131859 |
| 56 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.38644917 |
| 57 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.37493246 |
| 58 | P68_20966046_ChIP-Seq_HELA_Human | 1.35573925 |
| 59 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.34473906 |
| 60 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.33237394 |
| 61 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.33153555 |
| 62 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.32922073 |
| 63 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.31529550 |
| 64 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.30912843 |
| 65 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30188876 |
| 66 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.29833165 |
| 67 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.28333446 |
| 68 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.28202520 |
| 69 | MAF_26560356_Chip-Seq_TH1_Human | 1.27802422 |
| 70 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.26575051 |
| 71 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.25823528 |
| 72 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.24800325 |
| 73 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.24180673 |
| 74 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.23267424 |
| 75 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.23045304 |
| 76 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.22991964 |
| 77 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.22780100 |
| 78 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.22646353 |
| 79 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.21664171 |
| 80 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.21548485 |
| 81 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.18636532 |
| 82 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.17658396 |
| 83 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.16704939 |
| 84 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.15350128 |
| 85 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.14780713 |
| 86 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.14712147 |
| 87 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.14177170 |
| 88 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.13569497 |
| 89 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.12742327 |
| 90 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.11125110 |
| 91 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.10901104 |
| 92 | AR_19668381_ChIP-Seq_PC3_Human | 1.10633063 |
| 93 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.09633596 |
| 94 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.09586409 |
| 95 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09447526 |
| 96 | UTX_26944678_Chip-Seq_JUKART_Human | 1.09233638 |
| 97 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.08574826 |
| 98 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.07860495 |
| 99 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.07363641 |
| 100 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.07050711 |
| 101 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.05986195 |
| 102 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.05717829 |
| 103 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.05518773 |
| 104 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.05304567 |
| 105 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.03527007 |
| 106 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.03492574 |
| 107 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.02948618 |
| 108 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.02631060 |
| 109 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02629967 |
| 110 | MAF_26560356_Chip-Seq_TH2_Human | 1.02040016 |
| 111 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.01853943 |
| 112 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.01629228 |
| 113 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.01627603 |
| 114 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.01174524 |
| 115 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.00692157 |
| 116 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.00499626 |
| 117 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00424295 |
| 118 | ATF3_27146783_Chip-Seq_COLON_Human | 1.00118911 |
| 119 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99587486 |
| 120 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.99317358 |
| 121 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.99113845 |
| 122 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.98919813 |
| 123 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.98434386 |
| 124 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.98319644 |
| 125 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.98199775 |
| 126 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.98199775 |
| 127 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98113558 |
| 128 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.97866290 |
| 129 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.97736929 |
| 130 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.97675494 |
| 131 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.97614030 |
| 132 | RXR_22108803_ChIP-Seq_LS180_Human | 0.97178372 |
| 133 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.96827506 |
| 134 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.96732915 |
| 135 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.96377761 |
| 136 | GATA1_19941826_ChIP-Seq_K562_Human | 0.96328200 |
| 137 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.95633497 |
| 138 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93366664 |
| 139 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90721080 |
| 140 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.90502699 |
| 141 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.89305282 |
| 142 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.89066385 |
| 143 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.87418976 |
| 144 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.86422278 |
| 145 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.84401054 |
| 146 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.83767479 |
| 147 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.83276227 |
| 148 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 0.82099472 |
| 149 | SPI1_23127762_ChIP-Seq_K562_Human | 0.82090114 |
| 150 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.81071004 |
| 151 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.80985989 |
| 152 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.80725539 |
| 153 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.80087872 |
| 154 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.80082172 |
| 155 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.79899573 |
| 156 | TP53_16413492_ChIP-PET_HCT116_Human | 0.79732821 |
| 157 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.78762614 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.42679269 |
| 2 | MP0002822_catalepsy | 5.27984195 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.99102823 |
| 4 | MP0004270_analgesia | 3.30681744 |
| 5 | MP0009745_abnormal_behavioral_response | 3.19472987 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.16323909 |
| 7 | MP0003880_abnormal_central_pattern | 3.15970772 |
| 8 | MP0002064_seizures | 2.91559386 |
| 9 | MP0003566_abnormal_cell_adhesion | 2.67302059 |
| 10 | MP0005409_darkened_coat_color | 2.66013370 |
| 11 | MP0009046_muscle_twitch | 2.55675942 |
| 12 | MP0008260_abnormal_autophagy | 2.41009796 |
| 13 | MP0002909_abnormal_adrenal_gland | 2.37182278 |
| 14 | MP0002572_abnormal_emotion/affect_behav | 2.36892799 |
| 15 | MP0001849_ear_inflammation | 2.29577112 |
| 16 | MP0001486_abnormal_startle_reflex | 2.28224398 |
| 17 | MP0003436_decreased_susceptibility_to | 2.27012252 |
| 18 | MP0002796_impaired_skin_barrier | 2.24846589 |
| 19 | MP0009780_abnormal_chondrocyte_physiolo | 2.21423984 |
| 20 | MP0003453_abnormal_keratinocyte_physiol | 2.20030441 |
| 21 | MP0002272_abnormal_nervous_system | 2.19386954 |
| 22 | MP0001968_abnormal_touch/_nociception | 2.17853654 |
| 23 | MP0004858_abnormal_nervous_system | 2.17365334 |
| 24 | MP0003329_amyloid_beta_deposits | 2.16762113 |
| 25 | MP0004947_skin_inflammation | 2.08532688 |
| 26 | MP0005076_abnormal_cell_differentiation | 2.08240648 |
| 27 | MP0008569_lethality_at_weaning | 2.07528268 |
| 28 | MP0005423_abnormal_somatic_nervous | 2.07347343 |
| 29 | MP0001501_abnormal_sleep_pattern | 2.06545614 |
| 30 | MP0008961_abnormal_basal_metabolism | 2.00996050 |
| 31 | MP0005451_abnormal_body_composition | 1.97278098 |
| 32 | MP0003075_altered_response_to | 1.97030649 |
| 33 | MP0003091_abnormal_cell_migration | 1.93340828 |
| 34 | MP0002734_abnormal_mechanical_nocicepti | 1.90969136 |
| 35 | MP0000579_abnormal_nail_morphology | 1.79555105 |
| 36 | MP0010234_abnormal_vibrissa_follicle | 1.78940019 |
| 37 | MP0004885_abnormal_endolymph | 1.78311469 |
| 38 | MP0001958_emphysema | 1.73521795 |
| 39 | MP0004811_abnormal_neuron_physiology | 1.72104762 |
| 40 | MP0008438_abnormal_cutaneous_collagen | 1.67640848 |
| 41 | MP0005167_abnormal_blood-brain_barrier | 1.67512259 |
| 42 | MP0003879_abnormal_hair_cell | 1.62487019 |
| 43 | MP0003633_abnormal_nervous_system | 1.61345959 |
| 44 | MP0002733_abnormal_thermal_nociception | 1.59843023 |
| 45 | MP0003690_abnormal_glial_cell | 1.58300450 |
| 46 | MP0001440_abnormal_grooming_behavior | 1.55871324 |
| 47 | MP0001970_abnormal_pain_threshold | 1.54124229 |
| 48 | MP0004510_myositis | 1.51644964 |
| 49 | MP0000569_abnormal_digit_pigmentation | 1.48025738 |
| 50 | MP0002877_abnormal_melanocyte_morpholog | 1.44984169 |
| 51 | MP0009278_abnormal_bone_marrow | 1.44769459 |
| 52 | MP0005023_abnormal_wound_healing | 1.42844411 |
| 53 | MP0002736_abnormal_nociception_after | 1.42526844 |
| 54 | MP0005275_abnormal_skin_tensile | 1.41944201 |
| 55 | MP0003283_abnormal_digestive_organ | 1.41053546 |
| 56 | MP0000678_abnormal_parathyroid_gland | 1.40786955 |
| 57 | MP0008874_decreased_physiological_sensi | 1.39979215 |
| 58 | MP0004924_abnormal_behavior | 1.39204536 |
| 59 | MP0005386_behavior/neurological_phenoty | 1.39204536 |
| 60 | MP0000604_amyloidosis | 1.38893229 |
| 61 | MP0000858_altered_metastatic_potential | 1.34797083 |
| 62 | MP0004264_abnormal_extraembryonic_tissu | 1.34638510 |
| 63 | MP0002998_abnormal_bone_remodeling | 1.34611345 |
| 64 | MP0002735_abnormal_chemical_nociception | 1.34091003 |
| 65 | MP0002060_abnormal_skin_morphology | 1.33858417 |
| 66 | MP0002067_abnormal_sensory_capabilities | 1.31660992 |
| 67 | MP0003279_aneurysm | 1.30511740 |
| 68 | MP0005501_abnormal_skin_physiology | 1.29856263 |
| 69 | MP0002557_abnormal_social/conspecific_i | 1.29059901 |
| 70 | MP0000751_myopathy | 1.27904779 |
| 71 | MP0001851_eye_inflammation | 1.26832330 |
| 72 | MP0000955_abnormal_spinal_cord | 1.25881654 |
| 73 | MP0003172_abnormal_lysosome_physiology | 1.25025302 |
| 74 | MP0005464_abnormal_platelet_physiology | 1.23444747 |
| 75 | MP0003631_nervous_system_phenotype | 1.23043685 |
| 76 | MP0005666_abnormal_adipose_tissue | 1.22063967 |
| 77 | MP0002066_abnormal_motor_capabilities/c | 1.21070548 |
| 78 | MP0001533_abnormal_skeleton_physiology | 1.18919630 |
| 79 | MP0004381_abnormal_hair_follicle | 1.18133046 |
| 80 | MP0004130_abnormal_muscle_cell | 1.17978526 |
| 81 | MP0005646_abnormal_pituitary_gland | 1.17474367 |
| 82 | MP0008872_abnormal_physiological_respon | 1.16498187 |
| 83 | MP0003183_abnormal_peptide_metabolism | 1.14366908 |
| 84 | MP0000685_abnormal_immune_system | 1.09681296 |
| 85 | MP0000920_abnormal_myelination | 1.08533682 |
| 86 | MP0003705_abnormal_hypodermis_morpholog | 1.08029045 |
| 87 | MP0002419_abnormal_innate_immunity | 1.07489187 |
| 88 | MP0001216_abnormal_epidermal_layer | 1.06190492 |
| 89 | MP0005535_abnormal_body_temperature | 1.05644397 |
| 90 | MP0002184_abnormal_innervation | 1.04974452 |
| 91 | MP0002882_abnormal_neuron_morphology | 1.04188657 |
| 92 | MP0003300_gastrointestinal_ulcer | 1.03707647 |
| 93 | MP0010155_abnormal_intestine_physiology | 1.03192604 |
| 94 | MP0005025_abnormal_response_to | 1.01979308 |
| 95 | MP0003763_abnormal_thymus_physiology | 1.00522933 |
| 96 | MP0001177_atelectasis | 0.99827669 |
| 97 | MP0000467_abnormal_esophagus_morphology | 0.98139100 |
| 98 | MP0003045_fibrosis | 0.97102715 |
| 99 | MP0003303_peritoneal_inflammation | 0.96059706 |
| 100 | MP0001790_abnormal_immune_system | 0.94313010 |
| 101 | MP0005387_immune_system_phenotype | 0.94313010 |
| 102 | MP0003828_pulmonary_edema | 0.93669740 |
| 103 | MP0002069_abnormal_eating/drinking_beha | 0.93427190 |
| 104 | MP0005166_decreased_susceptibility_to | 0.92820805 |
| 105 | MP0005000_abnormal_immune_tolerance | 0.92473245 |
| 106 | MP0004782_abnormal_surfactant_physiolog | 0.90560683 |
| 107 | MP0001502_abnormal_circadian_rhythm | 0.90508446 |
| 108 | MP0010352_gastrointestinal_tract_polyps | 0.89019871 |
| 109 | MP0000778_abnormal_nervous_system | 0.88917124 |
| 110 | MP0000013_abnormal_adipose_tissue | 0.88599832 |
| 111 | MP0005257_abnormal_intraocular_pressure | 0.87936978 |
| 112 | MP0002090_abnormal_vision | 0.87410389 |
| 113 | MP0003866_abnormal_defecation | 0.87260443 |
| 114 | MP0002896_abnormal_bone_mineralization | 0.86604264 |
| 115 | MP0000566_synostosis | 0.86222082 |
| 116 | MP0004085_abnormal_heartbeat | 0.85448730 |
| 117 | MP0003634_abnormal_glial_cell | 0.83826361 |
| 118 | MP0009931_abnormal_skin_appearance | 0.82817536 |
| 119 | MP0005621_abnormal_cell_physiology | 0.82790642 |
| 120 | MP0000767_abnormal_smooth_muscle | 0.82191928 |
| 121 | MP0002249_abnormal_larynx_morphology | 0.82068285 |
| 122 | MP0003632_abnormal_nervous_system | 0.81715694 |
| 123 | MP0002254_reproductive_system_inflammat | 0.81564619 |
| 124 | MP0009333_abnormal_splenocyte_physiolog | 0.80141962 |
| 125 | MP0004272_abnormal_basement_membrane | 0.79016026 |
| 126 | MP0002152_abnormal_brain_morphology | 0.78602373 |
| 127 | MP0000747_muscle_weakness | 0.77820699 |
| 128 | MP0003724_increased_susceptibility_to | 0.76927238 |
| 129 | MP0004043_abnormal_pH_regulation | 0.76266342 |
| 130 | MP0003787_abnormal_imprinting | 0.75444172 |
| 131 | MP0002229_neurodegeneration | 0.75042805 |
| 132 | MP0002098_abnormal_vibrissa_morphology | 0.73378012 |
| 133 | MP0005623_abnormal_meninges_morphology | 0.73322977 |
| 134 | MP0005085_abnormal_gallbladder_physiolo | 0.72673844 |
| 135 | MP0002933_joint_inflammation | 0.72482193 |
| 136 | MP0005388_respiratory_system_phenotype | 0.72061678 |
| 137 | MP0002133_abnormal_respiratory_system | 0.72061678 |
| 138 | MP0010771_integument_phenotype | 0.71490743 |
| 139 | MP0000249_abnormal_blood_vessel | 0.70468237 |
| 140 | MP0006082_CNS_inflammation | 0.70157525 |
| 141 | MP0010329_abnormal_lipoprotein_level | 0.69690136 |
| 142 | MP0000733_abnormal_muscle_development | 0.69216259 |
| 143 | MP0006138_congestive_heart_failure | 0.68288339 |
| 144 | MP0003448_altered_tumor_morphology | 0.66068590 |
| 145 | MP0001915_intracranial_hemorrhage | 0.65982115 |
| 146 | MP0001819_abnormal_immune_cell | 0.65583485 |
| 147 | MP0001765_abnormal_ion_homeostasis | 0.64400815 |
| 148 | MP0001984_abnormal_olfaction | 0.63847117 |
| 149 | MP0000003_abnormal_adipose_tissue | 0.63143696 |
| 150 | MP0005360_urolithiasis | 0.60814778 |
| 151 | MP0003137_abnormal_impulse_conducting | 0.59142044 |
| 152 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.56739243 |
| 153 | MP0003191_abnormal_cellular_cholesterol | 0.56574411 |
| 154 | MP0004233_abnormal_muscle_weight | 0.56081780 |
| 155 | MP0004142_abnormal_muscle_tone | 0.55536898 |
| 156 | MP0009840_abnormal_foam_cell | 0.55375920 |
| 157 | MP0004087_abnormal_muscle_fiber | 0.55042461 |
| 158 | MP0001348_abnormal_lacrimal_gland | 0.54860737 |
| 159 | MP0002089_abnormal_postnatal_growth/wei | 0.53646028 |
| 160 | MP0002118_abnormal_lipid_homeostasis | 0.52334706 |
| 161 | MP0005058_abnormal_lysosome_morphology | 0.51665486 |
| 162 | MP0003252_abnormal_bile_duct | 0.51315562 |
| 163 | MP0004484_altered_response_of | 0.48841330 |
| 164 | MP0005448_abnormal_energy_balance | 0.48458411 |
| 165 | MP0005645_abnormal_hypothalamus_physiol | 0.48235195 |
| 166 | MP0004185_abnormal_adipocyte_glucose | 0.48213942 |
| 167 | MP0005375_adipose_tissue_phenotype | 0.46748090 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 6.95396517 |
| 2 | Focal motor seizures (HP:0011153) | 5.32946877 |
| 3 | Focal seizures (HP:0007359) | 4.52553947 |
| 4 | Action tremor (HP:0002345) | 4.16962321 |
| 5 | Visual hallucinations (HP:0002367) | 4.04276755 |
| 6 | Abnormality of the lower motor neuron (HP:0002366) | 3.45388173 |
| 7 | Annular pancreas (HP:0001734) | 3.44653268 |
| 8 | Supranuclear gaze palsy (HP:0000605) | 3.40172814 |
| 9 | Ankle clonus (HP:0011448) | 3.39874531 |
| 10 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.24440009 |
| 11 | Postural instability (HP:0002172) | 3.22244655 |
| 12 | Depression (HP:0000716) | 3.17699400 |
| 13 | Torticollis (HP:0000473) | 3.16569243 |
| 14 | Abnormal social behavior (HP:0012433) | 3.15975877 |
| 15 | Impaired social interactions (HP:0000735) | 3.15975877 |
| 16 | Dysmetric saccades (HP:0000641) | 3.09846696 |
| 17 | Poor eye contact (HP:0000817) | 3.07692588 |
| 18 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.00742782 |
| 19 | Resting tremor (HP:0002322) | 2.96652455 |
| 20 | Dysdiadochokinesis (HP:0002075) | 2.93735414 |
| 21 | Ventricular fibrillation (HP:0001663) | 2.90591563 |
| 22 | Broad face (HP:0000283) | 2.87997712 |
| 23 | Dysmetria (HP:0001310) | 2.86239904 |
| 24 | Hemiplegia (HP:0002301) | 2.85326611 |
| 25 | Urinary urgency (HP:0000012) | 2.83552035 |
| 26 | Intention tremor (HP:0002080) | 2.82450197 |
| 27 | Bundle branch block (HP:0011710) | 2.80867407 |
| 28 | Progressive cerebellar ataxia (HP:0002073) | 2.79444444 |
| 29 | Focal dystonia (HP:0004373) | 2.79388087 |
| 30 | Generalized tonic-clonic seizures (HP:0002069) | 2.75663479 |
| 31 | Pointed chin (HP:0000307) | 2.72940567 |
| 32 | Eczematoid dermatitis (HP:0000976) | 2.72397112 |
| 33 | Papilledema (HP:0001085) | 2.69318171 |
| 34 | Protrusio acetabuli (HP:0003179) | 2.68839792 |
| 35 | Epileptic encephalopathy (HP:0200134) | 2.68551975 |
| 36 | Anxiety (HP:0000739) | 2.68475848 |
| 37 | Absence seizures (HP:0002121) | 2.60232155 |
| 38 | Craniofacial dystonia (HP:0012179) | 2.60114925 |
| 39 | Distal upper limb amyotrophy (HP:0007149) | 2.59026312 |
| 40 | Upper limb amyotrophy (HP:0009129) | 2.59026312 |
| 41 | Insomnia (HP:0100785) | 2.58103059 |
| 42 | Atonic seizures (HP:0010819) | 2.52643025 |
| 43 | Febrile seizures (HP:0002373) | 2.52330562 |
| 44 | Increased IgE level (HP:0003212) | 2.49833669 |
| 45 | Lower limb amyotrophy (HP:0007210) | 2.49560364 |
| 46 | Gaze-evoked nystagmus (HP:0000640) | 2.49093201 |
| 47 | Cerebral inclusion bodies (HP:0100314) | 2.47559209 |
| 48 | Ankyloglossia (HP:0010296) | 2.42396293 |
| 49 | Impaired smooth pursuit (HP:0007772) | 2.40822360 |
| 50 | Spastic gait (HP:0002064) | 2.39576973 |
| 51 | Neurofibrillary tangles (HP:0002185) | 2.39057212 |
| 52 | Dialeptic seizures (HP:0011146) | 2.38639649 |
| 53 | Abnormal eating behavior (HP:0100738) | 2.36824549 |
| 54 | Genetic anticipation (HP:0003743) | 2.32972322 |
| 55 | Stereotypic behavior (HP:0000733) | 2.32161145 |
| 56 | Truncal ataxia (HP:0002078) | 2.30822741 |
| 57 | Scanning speech (HP:0002168) | 2.29957203 |
| 58 | Megalencephaly (HP:0001355) | 2.28862733 |
| 59 | Broad-based gait (HP:0002136) | 2.26949624 |
| 60 | Hyperacusis (HP:0010780) | 2.25778485 |
| 61 | Bradykinesia (HP:0002067) | 2.25680412 |
| 62 | Impaired vibratory sensation (HP:0002495) | 2.25286279 |
| 63 | Abnormality of the periventricular white matter (HP:0002518) | 2.24952565 |
| 64 | Thin bony cortex (HP:0002753) | 2.24778077 |
| 65 | Status epilepticus (HP:0002133) | 2.24579977 |
| 66 | Atrophic scars (HP:0001075) | 2.23976282 |
| 67 | Flat acetabular roof (HP:0003180) | 2.21609549 |
| 68 | Achilles tendon contracture (HP:0001771) | 2.20769768 |
| 69 | Shallow orbits (HP:0000586) | 2.18150766 |
| 70 | Hemorrhage of the eye (HP:0011885) | 2.17266456 |
| 71 | Abnormality of the Achilles tendon (HP:0005109) | 2.17151718 |
| 72 | Polygenic inheritance (HP:0010982) | 2.16357160 |
| 73 | Abnormality of nail color (HP:0100643) | 2.15837290 |
| 74 | Mutism (HP:0002300) | 2.12855659 |
| 75 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.12783806 |
| 76 | Milia (HP:0001056) | 2.11957264 |
| 77 | Termporal pattern (HP:0011008) | 2.10950114 |
| 78 | Insidious onset (HP:0003587) | 2.10950114 |
| 79 | Dysostosis multiplex (HP:0000943) | 2.10521209 |
| 80 | Increased connective tissue (HP:0009025) | 2.10440741 |
| 81 | Macroorchidism (HP:0000053) | 2.10173547 |
| 82 | Neuronal loss in central nervous system (HP:0002529) | 2.09622326 |
| 83 | Heart block (HP:0012722) | 2.07577509 |
| 84 | Atrioventricular block (HP:0001678) | 2.07177382 |
| 85 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.06826052 |
| 86 | Rapidly progressive (HP:0003678) | 2.05968706 |
| 87 | Clonus (HP:0002169) | 2.05467456 |
| 88 | Fragile skin (HP:0001030) | 2.05236529 |
| 89 | Thick nail (HP:0001805) | 2.04102305 |
| 90 | Onion bulb formation (HP:0003383) | 2.04000573 |
| 91 | Premature rupture of membranes (HP:0001788) | 2.02664174 |
| 92 | Distal lower limb muscle weakness (HP:0009053) | 2.01862968 |
| 93 | Interstitial pulmonary disease (HP:0006530) | 2.01790623 |
| 94 | Aneurysm (HP:0002617) | 2.01116163 |
| 95 | Cervical subluxation (HP:0003308) | 1.99750544 |
| 96 | Lower limb muscle weakness (HP:0007340) | 1.98722409 |
| 97 | Cellulitis (HP:0100658) | 1.97662674 |
| 98 | Abnormality of saccadic eye movements (HP:0000570) | 1.97609671 |
| 99 | Disproportionate tall stature (HP:0001519) | 1.97387240 |
| 100 | Arterial tortuosity (HP:0005116) | 1.97349385 |
| 101 | Lower limb asymmetry (HP:0100559) | 1.97216216 |
| 102 | Vertebral compression fractures (HP:0002953) | 1.96727774 |
| 103 | Abnormality of the fingertips (HP:0001211) | 1.95441213 |
| 104 | Obstructive sleep apnea (HP:0002870) | 1.93570692 |
| 105 | Deep venous thrombosis (HP:0002625) | 1.92341959 |
| 106 | Abnormal atrioventricular conduction (HP:0005150) | 1.92316820 |
| 107 | Turricephaly (HP:0000262) | 1.91832272 |
| 108 | Systemic lupus erythematosus (HP:0002725) | 1.91809571 |
| 109 | Spastic tetraparesis (HP:0001285) | 1.90321325 |
| 110 | Abnormality of oral frenula (HP:0000190) | 1.87358617 |
| 111 | Cerebral aneurysm (HP:0004944) | 1.87084686 |
| 112 | Abnormal EKG (HP:0003115) | 1.86079949 |
| 113 | Bronchomalacia (HP:0002780) | 1.85953771 |
| 114 | Prolonged QT interval (HP:0001657) | 1.85945282 |
| 115 | Elfin facies (HP:0004428) | 1.85536019 |
| 116 | Rigidity (HP:0002063) | 1.85325961 |
| 117 | Diplopia (HP:0000651) | 1.84556850 |
| 118 | Abnormality of binocular vision (HP:0011514) | 1.84556850 |
| 119 | Vascular tortuosity (HP:0004948) | 1.84286539 |
| 120 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.82776184 |
| 121 | Mucopolysacchariduria (HP:0008155) | 1.82776184 |
| 122 | Distal lower limb amyotrophy (HP:0008944) | 1.81772064 |
| 123 | Hammertoe (HP:0001765) | 1.80656502 |
| 124 | Tetraplegia (HP:0002445) | 1.80646963 |
| 125 | Dilatation of the ascending aorta (HP:0005111) | 1.80095162 |
| 126 | Slow saccadic eye movements (HP:0000514) | 1.79280852 |
| 127 | Malnutrition (HP:0004395) | 1.78331869 |
| 128 | Hyperparathyroidism (HP:0000843) | 1.76605053 |
| 129 | Amblyopia (HP:0000646) | 1.76119389 |
| 130 | Axonal loss (HP:0003447) | 1.75108058 |
| 131 | Hypercortisolism (HP:0001578) | 1.74321974 |
| 132 | Hemiparesis (HP:0001269) | 1.73202219 |
| 133 | Mitral regurgitation (HP:0001653) | 1.72965073 |
| 134 | Abnormality of macrophages (HP:0004311) | 1.72696008 |
| 135 | Gingivitis (HP:0000230) | 1.72095865 |
| 136 | Difficulty running (HP:0009046) | 1.71511692 |
| 137 | Advanced eruption of teeth (HP:0006288) | 1.71358755 |
| 138 | Ulnar bowing (HP:0003031) | 1.71236268 |
| 139 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.71099928 |
| 140 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.70486108 |
| 141 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.70486108 |
| 142 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.70486108 |
| 143 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.70401317 |
| 144 | Stridor (HP:0010307) | 1.70366588 |
| 145 | Neoplasm of the heart (HP:0100544) | 1.70139529 |
| 146 | Increased cerebral lipofuscin (HP:0011813) | 1.70016081 |
| 147 | Amyloidosis (HP:0011034) | 1.68705422 |
| 148 | Hand muscle atrophy (HP:0009130) | 1.68090689 |
| 149 | Abnormal blistering of the skin (HP:0008066) | 1.68040863 |
| 150 | Postural tremor (HP:0002174) | 1.67683446 |
| 151 | Spinal canal stenosis (HP:0003416) | 1.67665358 |
| 152 | Right ventricular cardiomyopathy (HP:0011663) | 1.66731636 |
| 153 | Increased variability in muscle fiber diameter (HP:0003557) | 1.64846069 |
| 154 | Colitis (HP:0002583) | 1.63158753 |
| 155 | Peripheral hypomyelination (HP:0007182) | 1.62979555 |
| 156 | Aortic aneurysm (HP:0004942) | 1.61876731 |
| 157 | Apathy (HP:0000741) | 1.61547560 |
| 158 | Long palpebral fissure (HP:0000637) | 1.60695012 |
| 159 | Plantar hyperkeratosis (HP:0007556) | 1.60095956 |
| 160 | Abnormality of complement system (HP:0005339) | 1.60047063 |
| 161 | Emphysema (HP:0002097) | 1.59868614 |
| 162 | Abnormality of the salivary glands (HP:0010286) | 1.59780874 |
| 163 | Loss of speech (HP:0002371) | 1.57187042 |
| 164 | Purpura (HP:0000979) | 1.56650993 |
| 165 | Nuclear cataract (HP:0100018) | 1.56617836 |
| 166 | Alopecia of scalp (HP:0002293) | 1.55204973 |
| 167 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.54874829 |
| 168 | Nail dystrophy (HP:0008404) | 1.54058486 |
| 169 | Wormian bones (HP:0002645) | 1.53721623 |
| 170 | Decreased motor nerve conduction velocity (HP:0003431) | 1.53145596 |
| 171 | Difficulty climbing stairs (HP:0003551) | 1.52273382 |
| 172 | Polycythemia (HP:0001901) | 1.51681949 |
| 173 | Distal sensory impairment (HP:0002936) | 1.51301803 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.73854717 |
| 2 | MAP3K9 | 3.61528087 |
| 3 | NTRK3 | 3.44975249 |
| 4 | PRKD3 | 3.02800202 |
| 5 | DAPK2 | 2.88755714 |
| 6 | KSR2 | 2.79605661 |
| 7 | ERN1 | 2.73524742 |
| 8 | SMG1 | 2.45368461 |
| 9 | CAMKK1 | 2.34785247 |
| 10 | PAK6 | 2.27074123 |
| 11 | CDK12 | 2.19864720 |
| 12 | TRIB3 | 2.18562117 |
| 13 | NTRK1 | 1.99433808 |
| 14 | MINK1 | 1.98150209 |
| 15 | MAP3K13 | 1.86368967 |
| 16 | RIPK1 | 1.85969903 |
| 17 | TAOK1 | 1.79037632 |
| 18 | MAP3K4 | 1.78923529 |
| 19 | RIPK4 | 1.76696253 |
| 20 | TYRO3 | 1.76270810 |
| 21 | NTRK2 | 1.71210810 |
| 22 | MAP3K2 | 1.67643104 |
| 23 | STK38 | 1.64969597 |
| 24 | MST1R | 1.59178609 |
| 25 | SIK2 | 1.52008871 |
| 26 | EPHA2 | 1.47234027 |
| 27 | CDK5 | 1.41354659 |
| 28 | FES | 1.39292676 |
| 29 | PRKCH | 1.36171825 |
| 30 | IRAK3 | 1.28327407 |
| 31 | DAPK1 | 1.28095725 |
| 32 | ALK | 1.26747823 |
| 33 | MAP2K4 | 1.26744338 |
| 34 | KSR1 | 1.26285432 |
| 35 | MAP2K3 | 1.24624653 |
| 36 | MAP4K1 | 1.21432994 |
| 37 | RET | 1.20808209 |
| 38 | MARK1 | 1.18450365 |
| 39 | LMTK2 | 1.16661384 |
| 40 | PKN2 | 1.15592964 |
| 41 | TYK2 | 1.15573754 |
| 42 | TTN | 1.14720252 |
| 43 | MAP3K3 | 1.14229972 |
| 44 | MAP3K7 | 1.13412165 |
| 45 | SGK3 | 1.07219016 |
| 46 | ZAP70 | 1.05485736 |
| 47 | STK11 | 1.00403766 |
| 48 | PDK1 | 0.99900893 |
| 49 | FGFR3 | 0.98548712 |
| 50 | PDPK1 | 0.98002994 |
| 51 | MAP3K1 | 0.96567293 |
| 52 | PRPF4B | 0.95543061 |
| 53 | MAP3K6 | 0.93815738 |
| 54 | CAMK1 | 0.93539973 |
| 55 | ARAF | 0.92859018 |
| 56 | PINK1 | 0.92647056 |
| 57 | PDGFRA | 0.92484991 |
| 58 | MARK2 | 0.91347150 |
| 59 | CAMK1G | 0.89378111 |
| 60 | ICK | 0.88937985 |
| 61 | DMPK | 0.86639164 |
| 62 | CAMKK2 | 0.86241412 |
| 63 | SGK494 | 0.85068773 |
| 64 | SGK223 | 0.85068773 |
| 65 | MAPK12 | 0.84284613 |
| 66 | UHMK1 | 0.83900928 |
| 67 | RAF1 | 0.83636934 |
| 68 | BMX | 0.82807715 |
| 69 | BLK | 0.82580299 |
| 70 | SIK3 | 0.81987173 |
| 71 | PTK2B | 0.81381977 |
| 72 | MAP3K11 | 0.81246578 |
| 73 | MTOR | 0.81168825 |
| 74 | TAOK2 | 0.81107789 |
| 75 | MAP3K10 | 0.80178802 |
| 76 | NEK1 | 0.75599304 |
| 77 | MET | 0.74309605 |
| 78 | CDC42BPA | 0.73901408 |
| 79 | TESK1 | 0.72444693 |
| 80 | JAK3 | 0.72102627 |
| 81 | SGK1 | 0.72027167 |
| 82 | PRKCG | 0.71655164 |
| 83 | MAP3K14 | 0.70874285 |
| 84 | CSK | 0.70729611 |
| 85 | CAMK4 | 0.70728697 |
| 86 | WNK1 | 0.70598188 |
| 87 | PHKG2 | 0.69599989 |
| 88 | PHKG1 | 0.69599989 |
| 89 | GRK5 | 0.69412941 |
| 90 | PAK4 | 0.68498452 |
| 91 | SGK2 | 0.67562012 |
| 92 | HIPK2 | 0.67432832 |
| 93 | MAP2K7 | 0.66228307 |
| 94 | DDR2 | 0.65463907 |
| 95 | PAK3 | 0.65113402 |
| 96 | TNK2 | 0.64496333 |
| 97 | GRK6 | 0.63955585 |
| 98 | FGR | 0.62748383 |
| 99 | TBK1 | 0.62200551 |
| 100 | SCYL2 | 0.61850367 |
| 101 | PRKD2 | 0.61756924 |
| 102 | FGFR2 | 0.60734081 |
| 103 | CDK15 | 0.59423564 |
| 104 | PRKG2 | 0.59418507 |
| 105 | MAPK7 | 0.58966618 |
| 106 | FYN | 0.57746569 |
| 107 | NEK6 | 0.57277587 |
| 108 | RPS6KA3 | 0.56329609 |
| 109 | CDK18 | 0.55815013 |
| 110 | JAK1 | 0.55552148 |
| 111 | MAPK11 | 0.52959039 |
| 112 | DAPK3 | 0.52689832 |
| 113 | CAMK2A | 0.52264852 |
| 114 | IRAK2 | 0.51844954 |
| 115 | PTK6 | 0.51750413 |
| 116 | MAP2K1 | 0.50971580 |
| 117 | PRKCZ | 0.50962248 |
| 118 | LATS2 | 0.50862355 |
| 119 | CDK14 | 0.50052049 |
| 120 | CDK11A | 0.50028643 |
| 121 | PRKD1 | 0.48501287 |
| 122 | JAK2 | 0.48057546 |
| 123 | PTK2 | 0.48026667 |
| 124 | RPS6KC1 | 0.47951284 |
| 125 | RPS6KL1 | 0.47951284 |
| 126 | PDGFRB | 0.47465671 |
| 127 | IRAK4 | 0.46901219 |
| 128 | CAMK1D | 0.46791568 |
| 129 | CDK19 | 0.45866348 |
| 130 | CSF1R | 0.45765800 |
| 131 | MAPK10 | 0.45672145 |
| 132 | TGFBR2 | 0.43298492 |
| 133 | FER | 0.42986119 |
| 134 | CAMK2B | 0.42504987 |
| 135 | EEF2K | 0.42504862 |
| 136 | EPHB1 | 0.40941873 |
| 137 | SIK1 | 0.39866034 |
| 138 | TNIK | 0.37993917 |
| 139 | HCK | 0.37936557 |
| 140 | MAP2K2 | 0.37378388 |
| 141 | RPS6KA2 | 0.36227072 |
| 142 | FGFR4 | 0.36124753 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.11451999 |
| 2 | Olfactory transduction_Homo sapiens_hsa04740 | 2.60638992 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.34084627 |
| 4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.20995096 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.19545983 |
| 6 | Long-term potentiation_Homo sapiens_hsa04720 | 2.18465588 |
| 7 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.09345139 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.03132333 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.02586250 |
| 10 | Nicotine addiction_Homo sapiens_hsa05033 | 2.01906973 |
| 11 | Other glycan degradation_Homo sapiens_hsa00511 | 1.97268244 |
| 12 | Morphine addiction_Homo sapiens_hsa05032 | 1.94369161 |
| 13 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.93721017 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 1.88638103 |
| 15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.87057252 |
| 16 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.79933511 |
| 17 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.76061852 |
| 18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.69253334 |
| 19 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.66673829 |
| 20 | Insulin secretion_Homo sapiens_hsa04911 | 1.64847871 |
| 21 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.60710652 |
| 22 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.60095470 |
| 23 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.54904542 |
| 24 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.53207686 |
| 25 | Cocaine addiction_Homo sapiens_hsa05030 | 1.51903219 |
| 26 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.47738171 |
| 27 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.46973403 |
| 28 | Renin secretion_Homo sapiens_hsa04924 | 1.44317570 |
| 29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.39940604 |
| 30 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.35310652 |
| 31 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.34713371 |
| 32 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.30130179 |
| 33 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.27735665 |
| 34 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.26412578 |
| 35 | Glioma_Homo sapiens_hsa05214 | 1.25549081 |
| 36 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.19592862 |
| 37 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.19373170 |
| 38 | Long-term depression_Homo sapiens_hsa04730 | 1.17444414 |
| 39 | Bile secretion_Homo sapiens_hsa04976 | 1.16936631 |
| 40 | Gap junction_Homo sapiens_hsa04540 | 1.16848260 |
| 41 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.15971138 |
| 42 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.15938887 |
| 43 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.15783835 |
| 44 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.13641779 |
| 45 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.12982044 |
| 46 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.10643561 |
| 47 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.08311405 |
| 48 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.07967400 |
| 49 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.06441410 |
| 50 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.00539628 |
| 51 | Focal adhesion_Homo sapiens_hsa04510 | 0.99107787 |
| 52 | Leishmaniasis_Homo sapiens_hsa05140 | 0.95271506 |
| 53 | Taste transduction_Homo sapiens_hsa04742 | 0.95211335 |
| 54 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.95162863 |
| 55 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.94878328 |
| 56 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.94343086 |
| 57 | Bladder cancer_Homo sapiens_hsa05219 | 0.92533417 |
| 58 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.88273516 |
| 59 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.88039103 |
| 60 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.86792279 |
| 61 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.86416670 |
| 62 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.86149300 |
| 63 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.86121177 |
| 64 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.85734818 |
| 65 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.84999334 |
| 66 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.84865315 |
| 67 | Melanogenesis_Homo sapiens_hsa04916 | 0.84734082 |
| 68 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.83872480 |
| 69 | Hepatitis C_Homo sapiens_hsa05160 | 0.83809768 |
| 70 | Tuberculosis_Homo sapiens_hsa05152 | 0.83536087 |
| 71 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.83434967 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.82036186 |
| 73 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.81896371 |
| 74 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.80730483 |
| 75 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.80317608 |
| 76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.80153077 |
| 77 | Lysosome_Homo sapiens_hsa04142 | 0.79961785 |
| 78 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.79917411 |
| 79 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.79883502 |
| 80 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.79857961 |
| 81 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.79820847 |
| 82 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.78014491 |
| 83 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.77642792 |
| 84 | Thyroid cancer_Homo sapiens_hsa05216 | 0.77291198 |
| 85 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.76959994 |
| 86 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.75870441 |
| 87 | Adherens junction_Homo sapiens_hsa04520 | 0.73846223 |
| 88 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.73210193 |
| 89 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.73048459 |
| 90 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.69764666 |
| 91 | Pertussis_Homo sapiens_hsa05133 | 0.69079941 |
| 92 | Axon guidance_Homo sapiens_hsa04360 | 0.67302045 |
| 93 | Influenza A_Homo sapiens_hsa05164 | 0.67047615 |
| 94 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.65765953 |
| 95 | Endocytosis_Homo sapiens_hsa04144 | 0.64965975 |
| 96 | Hepatitis B_Homo sapiens_hsa05161 | 0.64228157 |
| 97 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63990084 |
| 98 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.63946881 |
| 99 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.63763139 |
| 100 | Salmonella infection_Homo sapiens_hsa05132 | 0.62298777 |
| 101 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.62111033 |
| 102 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.60744642 |
| 103 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.59933476 |
| 104 | Apoptosis_Homo sapiens_hsa04210 | 0.58580828 |
| 105 | Galactose metabolism_Homo sapiens_hsa00052 | 0.58533731 |
| 106 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.57585210 |
| 107 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.57358370 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56847792 |
| 109 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.56808399 |
| 110 | Endometrial cancer_Homo sapiens_hsa05213 | 0.56751071 |
| 111 | Prion diseases_Homo sapiens_hsa05020 | 0.56430396 |
| 112 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.56260018 |
| 113 | Colorectal cancer_Homo sapiens_hsa05210 | 0.55666847 |
| 114 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54712990 |
| 115 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.54701127 |
| 116 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.54623059 |
| 117 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.52818981 |
| 118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51002054 |
| 119 | Insulin resistance_Homo sapiens_hsa04931 | 0.50821513 |
| 120 | Platelet activation_Homo sapiens_hsa04611 | 0.49544935 |
| 121 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.47495587 |
| 122 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46008289 |
| 123 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.45245473 |
| 124 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.43574011 |
| 125 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43458249 |
| 126 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.43307719 |
| 127 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.43092918 |
| 128 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.42091236 |
| 129 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.41515457 |
| 130 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.40724385 |
| 131 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.39887392 |
| 132 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.38796140 |
| 133 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.37951319 |
| 134 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.37089663 |
| 135 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.35277827 |
| 136 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.33161699 |
| 137 | Amoebiasis_Homo sapiens_hsa05146 | 0.33004072 |
| 138 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.31622362 |
| 139 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.31192413 |
| 140 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.30507837 |

